A randomized controlled trial evaluating efficacy of adjuvant oral uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: The UFT/LV study.

被引：4
|
作者：
Kobayashi, Akira
Hasegawa, Kiyoshi
Saiura, Akio
Takayama, Tadatoshi
Miyagawa, Shinichi
Yamamoto, Junji
Bandai, Yasutsugu
Teruya, Masanori
Yoshimi, Fuyo
Kawasaki, Seiji
Koyama, Hiroto
Oba, Masaru
Takahashi, Michiro
Mizunuma, Nobuyuki
Matsuyama, Yutaka
Watanabe, Toshiaki
Makuuchi, Masatoshi
Kokudo, Norihiro
机构：
[1] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano 390, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan
[3] Japanese Fdn Canc Res, Dept Surg Gastroenterol, Canc Inst Hosp, Tokyo, Japan
[4] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan
[5] Natl Def Med Coll, Dept Surg, Saitama, Japan
[6] Social Insurance Chuo Gen Hosp, Dept Surg, Tokyo, Japan
[7] Showa Gen Hosp, Dept Surg, Tokyo, Japan
[8] Ibaraki Prefectural Cent Hosp & Canc Ctr, Dept Surg, Ibaraki, Japan
[9] Juntendo Univ, Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo 113, Japan
[10] Sempos Tokyo Takanawa Hosp, Dept Surg, Tokyo, Japan
[11] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan
[12] Ariake Hosp, Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastrointestinal Surg, Tokyo, Japan
[13] JFCR, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
[14] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan
[15] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan
[16] Univ Tokyo, Fac Med, Tokyo 113, Japan
[17] Japanese Red Cross Med Ctr, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.3584
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3584
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Oral adjuvant chemotherapy using uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: Long-term survival results of the phase III UFT/LV study
    Hasegawa, Kiyoshi
    Saiura, Akio
    Takayama, Tadatoshi
    Miyagawa, Shinichi
    Yamamoto, Junji
    Bandai, Yasutsugu
    Teruya, Masanori
    Yoshimi, Fuyo
    Kawasaki, Seiji
    Koyama, Hiroto
    Oba, Masaru
    Takahashi, Michiro
    Yamashita, Suguru
    Mizunuma, Nobuyuki
    Matsuyama, Yutaka
    Watanabe, Toshiaki
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [2] Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial
    Hasegawa, Kiyoshi
    Saiura, Akio
    Takayama, Tadatoshi
    Miyagawa, Shinichi
    Yamamoto, Junji
    Ijichi, Masayoshi
    Teruya, Masanori
    Yoshimi, Fuyo
    Kawasaki, Seiji
    Koyama, Hiroto
    Oba, Masaru
    Takahashi, Michiro
    Mizunuma, Nobuyuki
    Matsuyama, Yutaka
    Watanabe, Toshiaki
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    PLOS ONE, 2016, 11 (09):
  • [3] Oral uracil/tegafur (UFT) plus leucovorin (LV) in patients with metastatic colorectal cancer (CRC)
    Goker, E
    Aykan, NF
    Serdengecti, S
    Gunel, N
    Alakavuklar, M
    Icli, F
    Yucel, I
    Uskent, N
    Arpaci, F
    Firat, D
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [4] Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients
    Meguro, Makoto
    Furuhata, Tomohisa
    Okita, Kenji
    Nishidate, Toshihiko
    Ishiyama, Gentaro
    Iwayama, Yuji
    Kimura, Yasutoshi
    Mizuguchi, Toru
    Hirata, Koichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (05) : 402 - 407
  • [5] Clinical compliance with an oral uracil/tegafur (UFT) plus leucovorin (LV) regimen as adjuvant chemotherapy in Japanese colorectal cancer patients
    Makoto Meguro
    Tomohisa Furuhata
    Kenji Okita
    Toshihiko Nishidate
    Gentaro Ishiyama
    Yuji Iwayama
    Yasutoshi Kimura
    Toru Mizuguchi
    Koichi Hirata
    International Journal of Clinical Oncology, 2009, 14 : 402 - 407
  • [6] Clinical identification of colorectal cancer patients benefiting from adjuvant uracil-tegafur (UFT): a randomized controlled trial
    Fujii, Masashi
    Takayama, Tadatoshi
    Kochi, Mitsugu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (12) : 1319 - 1323
  • [7] Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United States and Japan study of UFT/LV
    Shirao, K
    Hoff, PM
    Ohtsu, A
    Loehrer, PJ
    Hyodo, L
    Wadler, S
    Wadleigh, RG
    O'Dwyer, PJ
    Muro, K
    Yamada, Y
    Boku, N
    Nagashima, F
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (17) : 3466 - 3474
  • [8] A phase I study of oral uracil/tegafur (UFT) plus leucovorin (LV) combined with oxaliplatin in patients with metastatic colorectal cancer (CRC).
    Douillard, JY
    Dissoubray, C
    Seitz, JF
    CLINICAL CANCER RESEARCH, 2000, 6 : 4574S - 4574S
  • [9] Clinical identification of colorectal cancer patients benefiting from adjuvant uracil–tegafur (UFT): a randomized controlled trial
    Masashi Fujii
    Tadatoshi Takayama
    Mitsugu Kochi
    Journal of Cancer Research and Clinical Oncology, 2008, 134 : 1319 - 1323
  • [10] Bevacizumab (Bmab) in combination with uracil-tegafur (UFT) and oral leucovorin (LV) in elderly patients (≥75 years old) with metastatic colorectal cancer (mCRC): A multicenter phase II trial (J- BLUE study).
    Shimada, Mitsuo
    Nishina, Tomohiro
    Higashijima, Jun
    Moriwaki, Toshikazu
    Masuishi, Toshiki
    Sakai, Yoshinori
    Ozeki, Mitsuharu
    Negoro, Yuji
    Indou, Shunju
    Denda, Tadamichi
    Sato, Mikio
    Morimoto, Masamitsu
    Nakajima, Go
    Mizuta, Minoru
    Takahashi, Ikuo
    Hiroshima, Yoshinori
    Ishida, Hiroyasu
    Maeba, Takashi
    Hyodo, Ichinosuke
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345